Galapagos N.V. (GLPG) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$27.73
Price Target
$33.00
Target Range
$33.00 — $33.00
Analyst Rating
Hold
Forward P/E—
Trailing P/E4.9x
Forward PEG—
Implied Growth-143.8%
Median Target$33.00
Analyst Spread0.0%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$33
+19.0%
Consensus
$33
+19.0%
Bull Case
$33
+19.0%
GLPG Price Target Analysis
Updated May 8, 2026As of May 8, 2026, Galapagos N.V. (GLPG) has a Wall Street consensus price target of $33.00, based on estimates from 24 covering analysts. With the stock currently trading at $27.73, this represents a potential upside of +19.0%. The company has a market capitalization of $1.83B.
Analyst price targets range from a low of $33.00 to a high of $33.00, representing a 0% spread in expectations. The median target of $33.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 9 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 4 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, GLPG trades at a trailing P/E of 4.9x. Analysts expect EPS to grow -143.8% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+34.8%
Avg Forward P/E18.3x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ARCTArcturus Therapeutics Holdings Inc. | $253M | $8.90 | $22.50 | +152.8% | Buy | — | 21 |
 ACADACADIA Pharmaceuticals Inc. | $3.9B | $22.57 | $34.78 | +54.1% | Buy | 50.9x | 37 |
 HALOHalozyme Therapeutics, Inc. | $7.7B | $65.19 | $78.33 | +20.2% | Buy | 8.1x | 27 |
 EXELExelixis, Inc. | $11.7B | $46.21 | $45.71 | -1.1% | Buy | 14.0x | 32 |
 IONSIonis Pharmaceuticals, Inc. | $12.6B | $76.02 | $107.27 | +41.1% | Buy | — | 32 |
 INCYIncyte Corporation | $19.5B | $97.77 | $109.50 | +12.0% | Buy | 13.1x | 44 |
 ABBVAbbVie Inc. | $358.4B | $202.64 | $256.64 | +26.6% | Buy | 14.3x | 41 |
 LLYEli Lilly and Company | $921.2B | $974.96 | $1258.47 | +29.1% | Buy | 28.2x | 45 |
 PFEPfizer Inc. | $150.6B | $26.48 | $27.27 | +3.0% | Hold | 8.9x | 39 |
 BMYBristol-Myers Squibb Company | $114.8B | $56.25 | $62.00 | +10.2% | Hold | 8.9x | 41 |
Upside Potential Comparison
ARCTACADIONSLLYABBVHALOINCYBMYSee GLPG's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GLPG Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GLPG vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGLPG — Frequently Asked Questions
Quick answers to the most common questions about buying GLPG stock.
What is the GLPG stock price target for 2026?
Galapagos N.V. (GLPG) has a consensus 12-month price target of $33, implying 19.0% upside from $27.73. The 24 analysts covering GLPG see moderate appreciation potential.
Is GLPG a buy, sell, or hold?
GLPG has a consensus rating of "Hold" based on 24 Wall Street analysts. The rating breakdown is mixed, with 11 Hold ratings making up the largest segment. The consensus 12-month price target of $33 implies 19.0% upside from current levels.
Is GLPG stock overvalued or undervalued?
GLPG's current price is $27.73 with a consensus target of $33 (19.0% implied move). Analyst estimates suggest the stock is undervalued at current levels.
How high can GLPG stock go?
The most bullish Wall Street analyst has a price target of $33 for GLPG, while the most conservative target is $33. The consensus of $33 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover GLPG stock?
GLPG is well covered by analysts, with 24 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 9 have Buy ratings, 11 recommend Hold, and 4 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the GLPG stock forecast?
The 12-month GLPG stock forecast based on 24 Wall Street analysts shows a consensus price target of $33, with estimates ranging from $33 (bear case) to $33 (bull case). The median consensus rating is "Hold".
Should I buy GLPG stock?
Wall Street analysts are optimistic on GLPG, with a "Hold" consensus rating and $33 price target (19.0% upside). 9 of 24 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do GLPG price targets vary so much?
GLPG analyst price targets range from $33 to $33, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $33 consensus represents the middle ground.